There are 2789 resources available
238P - BOLERO-5: A phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER+/HER2- advanced breast cancer
Presenter: Zhimin Shao
Session: ePoster Display
239P - Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
Presenter: Marzia Del Re
Session: ePoster Display
240P - A real-world data analysis: The first United Kingdom experience of cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer in the National Health Service within an access program
Presenter: Carlo Palmieri
Session: ePoster Display
282P - Methylthioadenosine phosphorylase (MTAP) genomic loss in ERBB2 amplified (amp) and mutated (mut) (ERBB2+) metastatic breast cancer (MBC)
Presenter: Abirami Sivapiragasam
Session: ePoster Display
242P - Impact of metastases directed radiation therapy on CDK4/6 inhibitors treatment for metastatic breast cancer
Presenter: Icro Meattini
Session: ePoster Display
244P - Real-world first-line treatment patterns and outcomes in hormone-receptor positive advanced breast cancer patients: A multicenter, retrospective study
Presenter: Zhanhong Chen
Session: ePoster Display
286P - Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
Presenter: Cecile Bigot
Session: ePoster Display
287P - Burden of illness of HER2+ in metastatic breast cancer (MBC) patients: A systematic literature review (SLR)
Presenter: Gerard Vondeling
Session: ePoster Display